{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-041604","form_type":"8-K","ticker":"OPRX","cik":"0001448431","company_name":"OptimizeRx Corp","filed_at":"2026-04-09T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.302479+00:00","generated_at":"2026-05-15T06:46:58.582923+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"OptimizeRx appoints Microsoft Health COO Mary Varghese Presti to board","bullets":["Mary Varghese Presti appointed independent director effective April 3, 2026; board expanded to 7 members.","She serves on Audit Committee; receives $45k annual cash retainer plus $175k equity grant and $10k audit fee.","Varghese Presti is Microsoft Corporate VP & COO, Health & Life Sciences, with 25+ years in healthcare/tech.","CEO cites her experience in M&A, platform scaling, and commercialization as aligning with OptimizeRx strategy."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-041604","json":"https://secwatch.observer/filing/0001213900-26-041604.json","markdown":"https://secwatch.observer/filing/0001213900-26-041604.md","text":"https://secwatch.observer/filing/0001213900-26-041604.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1448431/000121390026041604/0001213900-26-041604-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1448431/000121390026041604/ea0285473-8k_optimize.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T06:46:58.582923+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}